360 related articles for article (PubMed ID: 33359845)
1. Combined the GABA-A and GABA-B receptor agonists attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
Yang JQ; Yang CH; Yin BQ
Behav Brain Res; 2021 Apr; 403():113094. PubMed ID: 33359845
[TBL] [Abstract][Full Text] [Related]
2. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism.
Kim JW; Seung H; Kim KC; Gonzales ELT; Oh HA; Yang SM; Ko MJ; Han SH; Banerjee S; Shin CY
Neuropharmacology; 2017 Feb; 113(Pt A):71-81. PubMed ID: 27638451
[TBL] [Abstract][Full Text] [Related]
3. The GABAB receptor agonist STX209 reverses the autism‑like behaviour in an animal model of autism induced by prenatal exposure to valproic acid.
Jiang S; Xiao L; Sun Y; He M; Gao C; Zhu C; Chang H; Ding J; Li W; Wang Y; Sun T; Wang F
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35244195
[TBL] [Abstract][Full Text] [Related]
4. 5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure.
Khodaverdi M; Rahdar M; Davoudi S; Hajisoltani R; Tavassoli Z; Ghasemi Z; Amini AE; Hosseinmardi N; Behzadi G; Janahmadi M
Neurobiol Learn Mem; 2021 Sep; 183():107462. PubMed ID: 34015444
[TBL] [Abstract][Full Text] [Related]
5. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
6. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
[TBL] [Abstract][Full Text] [Related]
7. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.
Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C
Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821
[TBL] [Abstract][Full Text] [Related]
8. Postweaning positive modulation of α5GABAA receptors improves autism-like features in prenatal valproate rat model in a sex-specific manner.
Santrač A; Bijelić D; Stevanović V; Banićević M; Aranđelović J; Batinić B; Sharmin D; Cook JM; Savić MM
Autism Res; 2022 May; 15(5):806-820. PubMed ID: 35266641
[TBL] [Abstract][Full Text] [Related]
9. Alteration of spontaneous spectral powers and coherences of local field potential in prenatal valproic acid mouse model of autism.
Cheaha D; Kumarnsit E
Acta Neurobiol Exp (Wars); 2015; 75(4):351-63. PubMed ID: 26994414
[TBL] [Abstract][Full Text] [Related]
10. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.
Mohammadi S; Asadi-Shekaari M; Basiri M; Parvan M; Shabani M; Nozari M
Psychopharmacology (Berl); 2020 Jan; 237(1):199-208. PubMed ID: 31595334
[TBL] [Abstract][Full Text] [Related]
11. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.
Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L
Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of striatal-enriched protein tyrosine phosphatase (STEP) activity reverses behavioral deficits in a rodent model of autism.
Chatterjee M; Singh P; Xu J; Lombroso PJ; Kurup PK
Behav Brain Res; 2020 Aug; 391():112713. PubMed ID: 32461127
[TBL] [Abstract][Full Text] [Related]
13. Size anomaly and alteration of GABAergic enzymes expressions in cerebellum of a valproic acid mouse model of autism.
Ma SY; Kwan KM
Behav Brain Res; 2022 Jun; 428():113896. PubMed ID: 35436531
[TBL] [Abstract][Full Text] [Related]
14. Maternal treatment with aripiprazole prevents the development of a valproic acid-induced autism-like phenotype in juvenile male mice.
de Oliveira Ferreira E; Pessoa Gomes JM; Neves KRT; Lima FAV; de Barros Viana GS; de Andrade GM
Behav Pharmacol; 2023 Apr; 34(2-3):154-168. PubMed ID: 36853856
[TBL] [Abstract][Full Text] [Related]
15. Administration of Atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism.
Liu C; Guo Z; Pang J; Zhang Y; Yang Z; Cao J; Zhang T
Behav Brain Res; 2024 Jul; 469():115052. PubMed ID: 38782096
[TBL] [Abstract][Full Text] [Related]
16. Perinatal exposure to BDE-47 exacerbated autistic-like behaviors and impairments of dendritic development in a valproic acid-induced rat model of autism.
Li Z; You M; Che X; Dai Y; Xu Y; Wang Y
Ecotoxicol Environ Saf; 2021 Apr; 212():112000. PubMed ID: 33550075
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid treated female Long-Evans rats are impaired on attentional set-shifting.
McKinnell ZE; Maze T; Ramos A; Challans B; Plakke B
Behav Brain Res; 2021 Jan; 397():112966. PubMed ID: 33053383
[TBL] [Abstract][Full Text] [Related]
18. Kami-shoyo-san ameliorates sociability deficits in ovariectomized mice, a putative female model of autism spectrum disorder, via facilitating dopamine D
Guo Q; Ebihara K; Fujiwara H; Toume K; Awale S; Araki R; Yabe T; Dong E; Matsumoto K
J Ethnopharmacol; 2019 May; 236():231-239. PubMed ID: 30862522
[TBL] [Abstract][Full Text] [Related]
19. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977
[TBL] [Abstract][Full Text] [Related]
20. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC
Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
